[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-403311-105":59,"doc-detail-403311-en":131},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":124,"head_meta":126,"extra_data":128,"updated_unix":130},105,"en","ashm-national-prep-guidelines-update-prevent-hiv-by-prescribing-prep-sydney-2021","ASHM National PrEP Guidelines Update - Prevent HIV by Prescribing PrEP - Sydney, 2021","","National PrEP Guidelines Update by the Australasian Society for HIV, Viral Hepatitis and Sexual Health Medicine (ASHM) for preventing HIV through prescribing PrEP. The update includes acknowledgements, a panel and reviewing committee, and editorial design and copy support. It provides guidance on PrEP safety and efficacy, indications in Australia, patient suitability, clinical assessment before initiation, prescribing and follow-up monitoring, special clinical considerations, adherence support, behavioural risk reduction, and accessing PrEP services. It also covers non-occupational post-exposure prophylaxis and pre-exposure prophylaxis and outlines delivery models.",{"@graph":69,"@context":123},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":35,"@type":76,"position":81},"https://docshare.wps.com/document/healthcare/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/ashm-national-prep-guidelines-update-prevent-hiv-by-prescribing-prep-sydney-2021/403311/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/ashm-national-prep-guidelines-update-prevent-hiv-by-prescribing-prep-sydney-2021/403311.png","ImageObject",300,407,{"name":92,"@type":93},"Theodore","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-30","2026-09-27",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",11,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"What is the purpose of the ASHM National PrEP Guidelines Update?","Question",{"text":113,"@type":114},"It provides national guidance on preventing HIV by prescribing PrEP, including safety, efficacy, eligibility, clinical assessment, prescribing, and ongoing monitoring.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"What topics are covered before starting and during PrEP use?",{"text":118,"@type":114},"The guidelines address PrEP safety and efficacy, indications and suitability, clinical assessment prior to initiation, how to provide PrEP, and clinical follow-up with monitoring.",{"name":120,"@type":111,"acceptedAnswer":121},"How does the document address access and implementation of PrEP in Australia?",{"text":122,"@type":114},"It includes sections on improving medication adherence, behavioural strategies to reduce risk, how to access PrEP, and models for PrEP delivery in clinical practice.","https://schema.org",{"og:url":83,"og:type":125,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":127,"canonical":83},"index,follow",{"doc_id":129,"site_id":62},403311,1790674067,{"code":4,"msg":5,"data":132},{"doc_id":129,"user_id":133,"nickname":92,"user_avatar":134,"doc_module":4,"category_id":34,"category_name":35,"doc_title":65,"doc_description":67,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":140,"language":141,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":67,"update_tm":145,"read_time":146,"preview_page_count":4},7971461740886,"https://ap-avatar.wpscdn.com/davatar_3d24733baf745e90a7e4bdd5f77d97b2","PREVENT HIV BY PRESCRIBING PrEP  \nPREVENT  \nHIV BY  \nPRESCRIBING  \nPrEP  \nSuggested citation:  \nThe Australasian Society for HIV, Viral Hepatitis and Sexual Health Medicine (ASHM) National PrEP Guidelines Update. Prevent HIV by Prescribing PrEP. Sydney, 2021  \nASHM received funding from the Australian Government to review and update the ASHM PrEP guidelines  \nACKNOWLEDGEMENT ~~ ~~ 03  \nAcknowledgement  \nPr EP GU IDELINES PANEL  \nChair Guidelines Panel: A/Prof Edwina Wright  \nInfectious Diseases Specialist, Department of Infectious Diseases, Monash University Central Clinical School, Honorary Principal Fellow, Burnet Institute, Honorary Associate Professor, Peter Doherty Institute for Infection and Immunity, Melbourne, VIC  \nDr Charlotte Bell  \nConsultant Sexual Health Physician  \nAdelaide Sexual Health Clinic, SA  \nDr Vincent Cornelisse  \nStaff specialist in sexual health medicine, Kirketon Road Centre, NSW Health.  \nConjoint senior lecturer, The Kirby Institute for Infection and Immunity in Society, UNSW  \nProf Andrew Grulich  \nHead, HIV Epidemiology and Prevention Program, The Kirby Institute, UNSW Sydney,  \nNSW  \nKate Bath  \nHIV Program Manager, ASHM, NSW  \nA/Prof Darren Russell  \nDirector of Sexual Health, Cairns Sexual Health Service, and James Cook University, QLD  \nBill Whittaker  \nRepresentative of Australian Federation of AIDS Organisations and National Association of People with HIV Australia  \nA/Prof Iryna Zablotska-Manos  \nHIV epidemiologist, the Sydney Medical School – Westmead, Faculty of Medicine and Health, The University of Sydney, NSW  \nASH M P r EP GU IDELINES  \nSECRETARIAT  \nChristopher Camacho  \nSenior Project Officer, ASHM, NSW  \nREVIEWING COMMITTEE  \nDr Mark Bloch  \nDirector Holdsworth House Medical Practice,  \nCon-joint A/Prof UNSW, President ASHM,  \nSydney, NSW  \nPhinn Borg  \nExecutive Director of The Gender Centre, Sydney, NSW  \nDr Adam Bourne  \nAssociate Professor, Australian Research  \nCentre in Sex, Health & Society,  \nLa Trobe University, Melbourne, VIC  \nProf Mark Boyd  \nMD, FRACP, Chair of Medicine, Lyell McEwin Hospital, University of Adelaide. Research Director, Northern Adelaide Local Health Network (NALHN), SA Health. Principal Research Fellow, SAHMRI. Visiting Professorial Fellow, Kirby Institute UNSW Australia. CoEditor-in-Chief, AIDS Research and Therapy, SA  \nJude Byrne  \nNational Coordinator of Peer Programs, AIVL, Canberra, ACT  \nTeddy Cook  \nManager, Trans & Gender Diverse Health Equity,  \nACON, Sydney, NSW  \nProf. Benjamin Cowie  \nDirector, WHO Collaborating Centre for Viral Hepatitis, Doherty Institute, Royal Melbourne Hospital, and Department of Medicine, University of Melbourne, Melbourne, VIC  \nDr Pauline Cundill  \nGeneral Practitioner and Medical Educator, Pandanus Medical NT and Northern Territory General Practice Education, Darwin, NT  \nA/Prof Philip Cunningham  \nChief Operating Officer, NSW State Reference Laboratory for HIV, Centre for Applied Medical Research, St Vincent’s Hospital, Sydney, NSW  \nDr Robert Finlayson  \nDirector, Sexual Health Medicine,  \nTaylor Square Private Clinic, Sydney, NSW  \nSally Goldner  \nAM, Educator and Treasurer,  \nTransgender Victoria Inc, Melbourne, VIC  \nA/Prof Michelle Giles  \nMBBS FRACP PhD, The Alfred Hospital, Royal Women’s Hospital, Monash Health and Sunshine Hospital, VIC  \nA/Prof David Gracey  \nRenal Unit, Royal Prince Alfred Hospital, Central Clinical School, Faculty of Medicine, University of Sydney, NSW  \nDr Manoji Gunathilake  \nSexual Health Physician, Sexual Health & Blood Borne Virus Unit, Northern Territory Department of Health, Darwin, NT. And Sexual Health Programme, Kirby Institute, UNSW, Sydney, NSW  \nJo Holden  \nDirector, Population Health Strategy & Performance, Centre for Population Health, NSW Ministry of Health, NSW  \nHollie Johnson  \nClinical Nurse Consultant, Keeping the Body in Mind Program, Eastern Suburbs Mental Health Service-SESLHD, NSW  \nKirsty Machon  \nExecutive Officer, Positive Women Victoria,  \nMelbourne, VIC ","cbCaiezz1Za5QtNe","https://ap.wps.com/l/cbCaiezz1Za5QtNe","pdf",724656,86,"English","# Content\n## Glossary\n## 1. Introduction\n## 2. PrEP safety and efficacy\n## 3. Indications for PrEP in Australia\n## 4. Suitability for PrEP\n## 5. Clinical assessment before starting PrEP\n## 6. Providing PrEP\n## 7. Clinical follow-up and monitoring of patients on PrEP\n## 8. Special Clinical considerations\n## 9. HIV non-occupational post-exposure prophylaxis and pre-exposure prophylaxis\n## 10. Improving medication adherence\n## 11. Behavioural strategies to reduce risk\n## 12. How to access PrEP in Australia\n## 13. Models of PREP delivery in clinical practice\n## 14. Suitability for PrEP-Parallel of Chapter 4\n## Appendix 1\n## Appendix 2\n## Appendix 3","[{\"question\":\"What is the purpose of the ASHM National PrEP Guidelines Update?\",\"answer\":\"It provides national guidance on preventing HIV by prescribing PrEP, including safety, efficacy, eligibility, clinical assessment, prescribing, and ongoing monitoring.\"},{\"question\":\"What topics are covered before starting and during PrEP use?\",\"answer\":\"The guidelines address PrEP safety and efficacy, indications and suitability, clinical assessment prior to initiation, how to provide PrEP, and clinical follow-up with monitoring.\"},{\"question\":\"How does the document address access and implementation of PrEP in Australia?\",\"answer\":\"It includes sections on improving medication adherence, behavioural strategies to reduce risk, how to access PrEP, and models for PrEP delivery in clinical practice.\"}]","ASHM National PrEP Guidelines Update - Prevent HIV by Prescribing PrEP - Sydney, 2021 | PDF",1790538857,217]